ORAI1 and transient myeloproliferative syndrome: TAM shares with Stormoken syndrome (STRMK) gain-of-function mutations of STIM1 and ORAI1 (104–106), leading to excess intracellular calcium influx, possibly favored by a reduced DES action on the SOCE pathway.